AzTrials
AzTrials

Edentulous Alveolar RidgeNCT03177356

Implant Placement in Mandibular Molar Xenograft Versus PRF

A study testing extraction,implant placement,PRF and Exctraction,Implant placement,Bone graft in people with Edentulous Alveolar Ridge, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

20 recruited patients indicated for immediate implant placement in mandibular molar patients are divided into 2 groups each group contain 15 patients, one group assigned for placement of bovine bone after molar extraction and immediate implant placement, while the other group we use Platelet-rich fibrin as space… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
extraction,implant placement,PRF and Exctraction,Implant placement,Bone graft
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Jul 2016to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with non-restorable mandibular molars
  • Both sexes
  • -

Who cannot join

  • • Heavy smokers more than 20 cigarettes per day.5
  • Patients with in sufficient interseptal bone height and width
  • Patients with systemic disease that may affect normal healing.
  • Patients with completely resorbed buccal cortical plate.

About this study

Official title: Immediate Implant Placement With Deproteinized Bovine Bone (Tutogen) Versus Placement of Platelet-rich Fibrin as a Space Filling Material in Mandibular Molars. Randomized Clinical Trial.

20 recruited patients indicated for immediate implant placement in mandibular molar patients are divided into 2 groups each group contain 15 patients, one group assigned for placement of bovine bone after molar extraction and immediate implant placement, while the other group we use Platelet-rich fibrin as space filling material.

Being tested
extraction,implant placement,PRF, Exctraction,Implant placement,Bone graft
Keywords
Platelet rich fibrin,xenograft

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • extraction,implant placement,PRFProcedure or surgery

    Surgical extraction of mandibular molar using periotome and forceps followed by implant placement in inter-septal bone. Then a blood sample is withdrawn from patient and placed in the centrifuge. Then Platelet-Rich fibrin is placed in the extraction socket as space filling material

  • Exctraction,Implant placement,Bone graftProcedure or surgery

    Surgical extraction of mandibular molar using extraction forceps and periotome followed by implant placement in interseptal bone. De-proteinized bovine bone graft material is placed as space filling material

Study groups in NCT03177356
Study groupRoleWhat they receive
extraction,implant placement,PRFExperimentalExtraction of Mandibular first molar and Implant placement followed by Placement of placement of Platelet rich fibrin as space filling material
Receives: Procedure: extraction,implant placement,PRF
Exctraction,Implant placement,Bone graftActive comparatorExtraction of mandibular first molar followed by implant placement and xenogenic bone graft as space filling material
Receives: Procedure: Exctraction,Implant placement,Bone graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient satisfaction

    evaluation of postoperative complications regarding pain and oedema

    Measured: 1 week post operative

Secondary outcomes (2)
  1. implant stability

    measurement of implant stability using osstell device

    Measured: will be measure intraopertively immediately after insertion of the implants and will be measure one more time 6 months after 1st operation at the time of exposure of implants

  2. amount of bone gained or lost around the implants

    two cone beam computed tomography (CBCT) will be taken for the patient, one immediate postoperative and the other 6 months after the operation then the height of bone gained or lost around the implants will be assessed by superimposing the same section in the two CBCTS

    Measured: 6 months postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2017
  2. Study startJul 2016
  3. Primary completionJul 2017 (estimated)
  4. Study completionJul 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03177356
Sponsor's protocol ID
cebc.cairouniversity
Status last verified
Jun 2017
First submitted
3 Jun 2017
Last updated
6 Jun 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing extraction,implant placement,PRF and Exctraction,Implant placement,Bone graft in people with Edentulous Alveolar Ridge, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient satisfaction (time frame: 1 week post operative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in